Medtronic (NYSE: MDT ) , one of the largest medical-device players on the planet, reported its fourth-quarter earnings today, and investors were clearly pleased with the results. Shares were up 4.9% by the market close, and this stock is up more than 30% over the past 12 months. But which segments drove the company's business in Q4? How did Medtronic's results measure up against its medical-device peers, like Boston Scientific (NYSE: BSX ) and St. Jude Medical (NYSE: STJ ) ? Health-care analyst Max Macaluso discusses these topics in the following video.
Medtronic is one of many companies facing a medical device-tax that is part of the Affordable Care Act, also known as Obamacare. This act has has far-reaching effects for both companies and individuals, and The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more.
RSS Headlines
Fool UK
Comments from our Foolish Readers
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the
Report this Comment icon found on every comment.
Be the first one to comment on this article.